Abnormal Uterine Bleeding. Abnormal Uterine and Vaginal Bleeding
Conditions
Interventions
Intervention 1: Intervention group:Anjebar booali daroo syrup and placebo syrup ( pharmaceutical company Booali Daroo). Take 15 ml every eight hour and Placebo capsule 250mg( pharmaceutical company
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Patient satisfaction Bleeding more than 7 days or periods less than 21 days Married women Patients 20 to 45 years Normal pap smear test Normal blood tests Normal endometrial thickness
Exclusion criteria
Exclusion criteria: Hormone therapy Pregnancy and lactation Diabetes Kidney disease Coagulants and cancers Hypothyroidism and hyperthyroidism Sub-mucosal or intramural fibroids larger than 5 cm, Active gastrointestinal bleeding Hemophilia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of menstrual bleeding. Timepoint: At the end of each cycle. Method of measurement: Hygam chart.;Pain. Timepoint: At the end of each cycle. Method of measurement: Questionnaire visual analog scale.;Menstrual period duration. Timepoint: At the end of each cycle. Method of measurement: Menorrhagia questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Yazdi
Ghoum University of Medical Sciences
Outcome results
None listed